Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life

OBJECTIVES: Myasthenia gravis (MG) may be refractory to traditional therapies. Quality of life (QOL) and disease burden in patients with refractory and nonrefractory MG were compared using Myasthenia Gravis Foundation of America MG Patient Registry data. METHODS: Adults aged 18 years or older with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Boscoe, Audra N., Xin, Haichang, L'Italien, Gilbert J., Harris, Linda A., Cutter, Gary R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Clinical Neuromuscular Disease 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571178/
https://www.ncbi.nlm.nih.gov/pubmed/31135620
http://dx.doi.org/10.1097/CND.0000000000000257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571178/
https://www.ncbi.nlm.nih.gov/pubmed/31135620
http://dx.doi.org/10.1097/CND.0000000000000257

Ejemplares similares